Tetanus immune globulin (CSL Behring)
N/A
Report date: 2024/01/23 10:54:08
Base Information
Drug NameTetanus immune globulin (CSL Behring)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date1993/05/01
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesCsl Behring Llc
China Registration ClassN/A
Develop Information
Other Information
ATC Code
Related LinksN/A